Log in

Tabula Rasa HealthCare Price Target, Predictions & Analyst Ratings

+0.58 (+1.66 %)
(As of 11/27/2020 12:00 AM ET)
Today's Range
Now: $35.57
50-Day Range
MA: $37.12
52-Week Range
Now: $35.57
Volume201,119 shs
Average Volume342,944 shs
Market Capitalization$847.56 million
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Tabula Rasa HealthCare (NASDAQ:TRHC) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
9 Wall Street analysts have issued ratings and price targets for Tabula Rasa HealthCare in the last 12 months. Their average twelve-month price target is $57.10, predicting that the stock has a possible upside of 60.53%. The high price target for TRHC is $83.00 and the low price target for TRHC is $38.00. There are currently 2 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
TRHC Consensus Rating: BuyBuyBuyBuy
TRHC Consensus Rating Score: 2.782.902.902.89
TRHC Analyst Ratings: 0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
TRHC Consensus Price Target: $57.10$65.30$66.60$71.67
TRHC Price Target Upside: 60.53% upside27.30% upside24.40% upside28.85% upside

Tabula Rasa HealthCare (NASDAQ:TRHC) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Tabula Rasa HealthCare (NASDAQ:TRHC) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/5/2020TruistLower Price Target$61.00 ➝ $41.00Medium
11/4/2020Piper SandlerLower Price TargetOverweight$59.00 ➝ $40.00High
11/4/2020SVB LeerinkDowngradeOutperform ➝ Market Perform$56.00 ➝ $38.00High
11/4/2020BenchmarkLower Price TargetBuy$65.00 ➝ $55.00High
9/23/2020Royal Bank of CanadaReiterated RatingBuy$57.00Low
8/12/2020Truist FinancialLower Price Target$72.00 ➝ $61.00Low
8/6/2020Wells Fargo & CompanyLower Price TargetEqual Weight$53.00 ➝ $46.00Medium
7/2/2020SunTrust BanksInitiated CoverageBuy$72.00High
6/25/2020Cantor FitzgeraldLower Price TargetPositive ➝ Overweight$85.00 ➝ $83.00Low
2/14/2020OppenheimerInitiated CoverageBuy$78.00Low
1/17/2020William BlairReiterated RatingOutperformLow
11/8/2019Piper Jaffray CompaniesLower Price TargetOverweight$78.00 ➝ $66.00High
8/30/2019Stifel NicolausUpgradeHold ➝ Buy$50.00 ➝ $75.00High
4/17/2019GuggenheimInitiated CoverageNeutral ➝ Neutral$58.00Medium
3/11/2019First AnalysisUpgradeOutperform ➝ Strong-Buy$58.33High
11/7/2018Chardan CapitalBoost Price TargetBuy$77.00 ➝ $91.00High
10/11/2018CitigroupBoost Price TargetBuy$100.00Medium
9/19/2018Robert W. BairdBoost Price TargetOutperform$70.00 ➝ $90.00Low
3/13/2018CIBCReiterated RatingOutperform ➝ Outperform$35.00 ➝ $47.00Medium
(Data available from 11/29/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 11/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.